These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36056222)

  • 1. Contemporary approach to catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Kattel S; Enriquez AD
    J Interv Card Electrophysiol; 2023 Apr; 66(3):793-805. PubMed ID: 36056222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.
    Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S
    J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substrate and ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Liuba I; Marchlinski FE
    Circ J; 2013; 77(8):1957-66. PubMed ID: 23856652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction.
    Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S
    Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic Ventricular Tachycardias in Nonischemic Cardiomyopathy.
    Nazer B; Hsia HH
    Card Electrophysiol Clin; 2016 Mar; 8(1):131-7. PubMed ID: 26920181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches.
    Bhaskaran A; Tung R; Stevenson WG; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):84-101. PubMed ID: 30385114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
    J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.
    Vaseghi M; Hu TY; Tung R; Vergara P; Frankel DS; Di Biase L; Tedrow UB; Gornbein JA; Yu R; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Burkhardt JD; Tholakanahalli VN; Dickfeld TM; Weiss JP; Bunch TJ; Reddy M; Callans DJ; Lakkireddy DR; Natale A; Marchlinski FE; Stevenson WG; Della Bella P; Shivkumar K
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1141-1150. PubMed ID: 30236386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Mathuria N; Tung R; Shivkumar K
    Curr Cardiol Rep; 2012 Oct; 14(5):577-83. PubMed ID: 22843484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy.
    Yang J; Liang J; Shirai Y; Muser D; Garcia FC; Callans DJ; Marchlinski FE; Santangeli P
    Heart Rhythm; 2019 Jun; 16(6):863-870. PubMed ID: 30576879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia.
    Gökoğlan Y; Mohanty S; Gianni C; Santangeli P; Trivedi C; Güneş MF; Bai R; Al-Ahmad A; Gallinghouse GJ; Horton R; Hranitzky PM; Sanchez JE; Beheiry S; Hongo R; Lakkireddy D; Reddy M; Schweikert RA; Dello Russo A; Casella M; Tondo C; Burkhardt JD; Themistoclakis S; Di Biase L; Natale A
    J Am Coll Cardiol; 2016 Nov; 68(18):1990-1998. PubMed ID: 27788854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of septal late gadolinium enhancement on cardiac magnetic resonance with ventricular tachycardia ablation targets in nonischemic cardiomyopathy.
    Kuo L; Liang JJ; Han Y; Frankel DS; Santangeli P; Callans DJ; Zado ES; Marchlinski FE; Desjardins B; Nazarian S
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3262-3276. PubMed ID: 33070414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
    Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
    Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus rhythm QRS amplitude and fractionation in patients with nonischemic cardiomyopathy to identify ventricular tachycardia substrate and location.
    Arceluz MR; Liuba I; Tschabrunn CM; Frankel DS; Santangeli P; Supple GE; Schaller RD; Garcia FC; Callans DJ; Guandalini GS; Walsh K; Nazarian S; Zado ES; Marchlinski FE
    Heart Rhythm; 2022 Feb; 19(2):187-194. PubMed ID: 34601127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.